Abstract
5-HT1 and 5-HT1A binding sites were measured in brain tissue obtained at postmortem from 19 suicides, with definite evidence of depression, and 19 sex and age-matched controls. Thirteen of the depressed suicides had not been prescribed psychoactive drugs recently (drug-free suicides); six had been receiving antidepressant drugs, alone or in combination with other drugs (antidepressant-treated suicides). No significant differences were found in the number or affinity of 5-HT1 and 5-HT1A binding sites in frontal or temporal cortex between drug-free suicides and controls. The number of 5-HT1 sites was significantly lower (by 20%), affinity unaltered, in hippocampus and the affinity significantly lower (by 33%), number unaltered, in amygdala of drug-free suicides than controls. The number of 5-HT1 binding sites tended to be higher and the affinity lower in the antidepressant-treated compared to drug-free suicides, and significantly so in hippocampus. The present results, together with our previous studies, provide no evidence of altered cortical 5-HT markers in depressed suicides, but further emphasise abnormalities in the hippocampus.
This is a preview of subscription content, log in via an institution to check access.
References
Agren H (1980) Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide. Psychiatry Res 3:225–236
Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Sims NR, Smith CCT, Spillane JA, Bowen DM, Davison AN (1983) Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. J Neurochem 41:256–265
Asberg M, Träskman L, Thorén P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197
Banki CM, Arato M (1983) Amine metabolites and neuroendocrine responses related to depression and suicide. J Affective Disord 5:223–232
Barraclough B, Hughes J (1987) Suicide. Clinical and epidemiological studies. Croom Helm, London
Beskow J, Gottfries CG, Roos BE, Winblad B (1976) Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7–20
Cheetham SC, Horton RW (1989) [3H]5-HT binding in post-mortem human cerebral cortex: methodological considerations. J Neural Transm 78:53–59
Cheetham SC, Crompton MR, Katona CLE, Horton RW (1988) Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443:272–280
Cheetham SC, Crompton MR, Czudek C, Horton RW, Katona CLE, Reynolds GP (1989a) Serotonin concentrations and turnover in brains of depressed suicides. Brain Res 502:332–340
Cheetham SC, Yamaguchi Y, Horton RW (1989b) [3H]5-hydroxytryptamine binding sites in postmortem human brain. Neuropharmacology 28:1055–1060
Coppen A, Swade C, Wood K (1978) Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta 87:165–168
Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561–1569
Goodwin GM, De Souza JR, Green AR (1985) The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Neuropharmacology 24:1187–1194
Goodwin GM, De Souza JR, Green AR (1987a) Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology 91:500–505
Goodwin GM, De Souza JR, Green AR, Heal DJ (1987b) The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 91:506–511
Heltzel JA, Boehme DH, Vogel WH (1981) Serotonin binding to different regions of human brain. Brain Res 204:451–454
Heuring RE, Peroutka SJ (1987) Characterization of a novel3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in human brain. 1. Characterization and autographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Lawrence KM, De Paermentier F, Cheetham SC, Crompton MR, Katona CLE, Horton RW (1990) Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res (in press)
Leonhardt S, Herrick-Davis K, Titeler M (1989) Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein. J Neurochem 53:465–471
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Marcusson J, Oreland L, Winblad B (1984) Effect of age on human brain serotonin (S-1) binding sites. J Neurochem 43:1699–1705
Martin KL, Phillips I, Heal DJ, Buckett WR (1989) Is down-regulation of 5-HT1A receptor function a common feature of the action of antidepressant drugs. Br J Pharmacol 97:407P
McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D (1987) 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affective Disord 13:67–74
Mellerup ET, Plenge P (1988) Imipramine binding in depression and other psychiatric disorders. Acta Psychiatr Scand [Suppl 345] 78:61–68
Ogren S-O, Fuxe K (1985) Effects of antidepressant drugs on serotonin receptor mechanisms. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford, pp 131–180
Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M (1986) Serotonergic mechanisms in brains of suicide victims. Brain Res 362:185–188
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205–230
Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain- III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97–122
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ (1988) 5-hydroxytryptamine receptor subtypes. Annu Rev Neurosci 11:45–60
Raisman R, Briley MS, Bouchami F, Sechter D, Zarifian E, Langer SZ (1982)3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacology 77:332–335
Sugrue MF (1983) Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol Ther 21:1–33
Tuomisto J, Tukiainen E, Ahlfors UG (1979) Decreases uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 65:141–147
Van Praag HM (1982) Depression, suicide and the metabolism of serotonin in the brain. J Affective Disord 4:275–290
Willner P (1985) Depression, a psychobiological synthesis. Wiley, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheetham, S.C., Crompton, M.R., Katona, C.L.E. et al. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology 102, 544–548 (1990). https://doi.org/10.1007/BF02247138
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247138